Immunocore Holdings (IMCR) Other Non-Current Liabilities (2019 - 2025)

Immunocore Holdings has disclosed Other Non-Current Liabilities across 7 years of filings, most recently posting $96.6 million for Q3 2025.

• Other Non-Current Liabilities for Q3 2025 came in at $96.6 million, up 3113.71% year-over-year; the trailing twelve-month figure through Sep 2025 was $96.6 million (up 3113.71% YoY), and the FY2023 annual result was $978000.0, down 55.85% from the prior year.
• Other Non-Current Liabilities came in at $96.6 million for Q3 2025 at Immunocore Holdings, up from $84.0 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $96.6 million in Q3 2025 to a low of $76836.6 in Q4 2021.
• The 5-year median for Other Non-Current Liabilities is $2.2 million (2024), against an average of $27.9 million.
• Across the five-year window, Other Non-Current Liabilities tumbled 57.83% in 2021 and soared 3919.15% in 2025, its largest moves.
• Immunocore Holdings' Other Non-Current Liabilities stood at $76836.6 in 2021, then jumped by 74.02% to $133713.8 in 2022, then soared by 631.41% to $978000.0 in 2023, then soared by 207.36% to $3.0 million in 2024, then jumped by 3113.71% to $96.6 million in 2025.
• The last three Other Non-Current Liabilities figures came in at $96.6 million (Q3 2025), $84.0 million (Q2 2025), and $62.5 million (Q1 2025), per Business Quant data.